Exponent (EXPO) Expected to Announce Earnings on Thursday

Exponent (NASDAQ:EXPO) is projected to post its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $0.5960 per share and revenue of $149.48 million for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 29, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.05. The firm had revenue of $171.61 million during the quarter, compared to analyst estimates of $144.99 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The business’s revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the business earned $0.52 EPS. On average, analysts expect Exponent to post $2.31 EPS for the current fiscal year and $2.67 EPS for the next fiscal year.

Exponent Trading Up 0.8%

Exponent stock opened at $73.15 on Thursday. Exponent has a 12-month low of $51.91 and a 12-month high of $81.95. The firm has a 50-day moving average price of $68.84 and a 200-day moving average price of $64.38. The firm has a market capitalization of $3.48 billion, a PE ratio of 32.80 and a beta of 0.69.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Friday, September 4th were given a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, September 4th. Exponent’s dividend payout ratio is 55.61%.

Insider Buying and Selling

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $66.28, for a total value of $113,139.96. Following the transaction, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. This represents a 1.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Weiss Ratings raised shares of Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. UBS Group set a $72.00 target price on Exponent and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, JPMorgan Chase & Co. upped their target price on Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Exponent has a consensus rating of “Moderate Buy” and an average price target of $81.00.

About Exponent

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.